A review of vaccine research and development: human acute respiratory infections. (Q30351377)

20 June 2017

1 reference

title

A review of vaccine research and development: human acute respiratory infections. (English)

1 reference

20 June 2017

1 reference

4

Marie Paule Kieny

1 reference

20 June 2017

Marc P Girard

1

1 reference

20 June 2017

Thomas Cherian

series ordinal

2

1 reference

20 June 2017

Yuri Pervikov

series ordinal

3

1 reference

20 June 2017

language of work or name

English

0 references

publication date

3 August 2005

1 reference

20 June 2017

1 reference

20 June 2017

23

1 reference

20 June 2017

5708-5724

1 reference

20 June 2017

50

1 reference

Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil

20 June 2017

1 reference

12 December 2020

Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.

1 reference

12 December 2020

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections

1 reference

12 December 2020

DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.

1 reference

12 December 2020

Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods

1 reference

12 December 2020

Are we ready for pandemic influenza?

1 reference

12 December 2020

1 reference

12 December 2020

Influenza: girding for disaster. Looking the pandemic in the eye

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

1 reference

12 December 2020

A role for immune complexes in enhanced respiratory syncytial virus disease

1 reference

12 December 2020

Immunoprophylaxis of respiratory syncytial virus: global experience

1 reference

12 December 2020

Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial

1 reference

12 December 2020

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.

1 reference

12 December 2020

A previously undescribed coronavirus associated with respiratory disease in humans

1 reference

12 December 2020

Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998.

1 reference

12 December 2020

Respiratory syncytial virus infection in adults

1 reference

12 December 2020

Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine

1 reference

12 December 2020

National disease burden of respiratory viruses detected in children by polymerase chain reaction

1 reference

12 December 2020

The economic impact of pandemic influenza in the United States: priorities for intervention.

1 reference

12 December 2020

A role for Streptococcus pneumoniae in virus-associated pneumonia

1 reference

12 December 2020

Influenza: girding for disaster. Facing down pandemic flu, the world's defenses are weak

1 reference

12 December 2020

Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials

1 reference

12 December 2020

The classification of viruses infecting the respiratory tract

1 reference

12 December 2020

Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b

1 reference

12 December 2020

The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants

1 reference

12 December 2020

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

1 reference

12 December 2020

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

1 reference

12 December 2020

Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries

1 reference

12 December 2020

Full-length influenza hemagglutinin HA2 refolds into the trimeric low-pH-induced conformation.

1 reference

12 December 2020

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

1 reference

12 December 2020

Haemophilus influenzae type b conjugate vaccines: a review of efficacy data

1 reference

12 December 2020

Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa

1 reference

12 December 2020

Inhibition of respiratory viruses by nasally administered siRNA.

1 reference

12 December 2020

Influenza: emergence and control

1 reference

12 December 2020

Cases of influenza A (H5N1)--Thailand, 2004.

1 reference

12 December 2020

Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys

1 reference

12 December 2020

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

12 December 2020

H5N1 influenza: a protean pandemic threat

1 reference

12 December 2020

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

1 reference

12 December 2020

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis

1 reference

12 December 2020

A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge

1 reference

12 December 2020

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Haemophilus influenzae type b vaccines: history, choice and comparisons

1 reference

12 December 2020

The etiology of lobar pneumonia in the Gambia.

1 reference

12 December 2020

A "universal" human influenza A vaccine

1 reference

12 December 2020

Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis

1 reference

12 December 2020

Estimates of world-wide distribution of child deaths from acute respiratory infections

1 reference

12 December 2020

Respiratory syncytial virus infection in tropical and developing countries

1 reference

12 December 2020

Novel generations of influenza vaccines

1 reference

12 December 2020

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

1 reference

12 December 2020

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

12 December 2020

Human metapneumovirus as a major cause of human respiratory tract disease

1 reference

12 December 2020

Public health. Will vaccines be available for the next influenza pandemic?

1 reference

12 December 2020

The etiology of pneumonia in malnourished and well-nourished Gambian children

1 reference

12 December 2020

Current status of live attenuated influenza virus vaccine in the US.

1 reference

12 December 2020

A newly discovered human pneumovirus isolated from young children with respiratory tract disease

1 reference

12 December 2020

Pneumococcal conjugate vaccines--a European perspective

1 reference

12 December 2020

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

12 December 2020

Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia

1 reference

12 December 2020

Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human PIV1 in the upper and lower respiratory tract of African green monkeys and chimpanzees

1 reference

12 December 2020

Identification of a new human coronavirus

1 reference

12 December 2020

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

1 reference

12 December 2020

Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States

1 reference

12 December 2020

Protection of the elderly from pneumococcal pneumonia with a protein-based vaccine?

1 reference

12 December 2020

Influenza pandemics: can we prepare for the unpredictable?

1 reference

12 December 2020

The many mechanisms of viral membrane fusion proteins.

1 reference

12 December 2020

Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

1 reference

12 December 2020

Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion

1 reference

12 December 2020

Live cold-adapted influenza A vaccine produced in Vero cell line

1 reference

12 December 2020

Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004

1 reference

12 December 2020

Impact of the pneumococcal conjugate vaccine on otitis media

1 reference

12 December 2020

The structural biology of type I viral membrane fusion

1 reference

12 December 2020

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

12 December 2020

Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections

1 reference

12 December 2020

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

1 reference

12 December 2020

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

1 reference

12 December 2020

Influenza: old and new threats

1 reference

12 December 2020

The severe acute respiratory syndrome

1 reference

12 December 2020

Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea

1 reference

12 December 2020

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

1 reference

12 December 2020

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics

1 reference

12 December 2020

Pneumococcal vaccines: an update on current strategies.

1 reference

12 December 2020

Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

1 reference

12 December 2020

Infectious diseases. True numbers remain elusive in bird flu outbreak

1 reference

12 December 2020

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

1 reference

12 December 2020

Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates

1 reference

12 December 2020

Severe acute respiratory syndrome

1 reference

12 December 2020

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

1 reference

12 December 2020

Severe acute respiratory syndrome: an update

1 reference

12 December 2020

Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease

1 reference

12 December 2020

The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex

1 reference

12 December 2020

Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002.

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

Controlling influenza by inhibiting the virus's neuraminidase.

1 reference

12 December 2020

Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation

1 reference

12 December 2020

10.1016/J.VACCINE.2005.07.046

Identifiers

DOI

1 reference

20 June 2017

0 references

1 reference